Poster: Drug/Disease Modelling - Absorption & PBPK

Simulations of the paliperidone pharmacokinetics of intramuscular long-acting injectable microsuspensions of paliperidone palmitate in rats using a mechanistic model

Thursday 16 October, 2025

Objectives: The objective of the present work was to develop a mechanism-based model that can predict the in vivo pharmacokinetic…

Read more

Extrapolation of lung pharmacokinetics of antitubercular drugs from preclinical species to humans using PBPK modeling

Thursday 16 October, 2025

Introduction Drugs against pulmonary tuberculosis (TB) need to be transported from the blood to the lung of TB patients and…

Read more

PBBM of ibuprofen enantiomers in tablets: in silico exploration of bioequivalence studies design

Thursday 16 October, 2025

Introduction: Physiologically-based pharmacokinetic (PBPK) modelling has recently shown powerful prediction capabilities for drug exposure in humans and other species. However,…

Read more

Pharmacokinetic Modeling of Ticagrelor in the Presence of Morphine in Healthy Volunteers

Thursday 16 October, 2025

Objectives: Ticagrelor is a P2Y12 receptor antagonist used to prevent thrombotic events in patients with acute coronary syndromes. Morphine, commonly…

Read more

Model-based exploration of the P-glycoprotein concentration-activity relationship shows a drug and system dependency: implications for mechanistic PBPK modelling of active transporter activity

Thursday 16 October, 2025

Objectives Active transporters like P-glycoprotein (P-gp) expressed at the Blood-Brain-Border (BBB) limit the distribution of drugs to the central nervous…

Read more

Analysis of the absorption processes using the top-down PBFTPK models Impact on the bottom up PBPK modeling work

Thursday 16 October, 2025

Introduction: The introduction of the Finite Absorption Time (F.A.T.) [1,2] concept led to the development of PBFTPK models [3-6]. These…

Read more

FTPK (Finite Time Pharmacokinetic) software for the analysis of pharmacokinetic data

Thursday 16 October, 2025

Introduction: The concept of finite absorption time (F.A.T.) has led to the development of physiologically based finite time pharmacokinetic (PBFTPK)…

Read more

A Physiologically-Based Computational Model of Bilirubin Metabolism: Integrating Real-World Data for Enhanced Clinical Evidence

Thursday 16 October, 2025

Introduction: Bilirubin plays a crucial role in the body’s elimination of hemoglobin and heme-containing proteins. Following its initial synthesis in…

Read more

A Phisiological-Based Pharmacokinetic model for CD25 Regulatory T cells targeted nanoparticles

Thursday 16 October, 2025

Introduction: Although immunotherapy (IT) has transformed cancer treatment, tumors can evade immunosurveillance by inducing infiltration of immune cells such as…

Read more

A Physiologically Based Pharmacokinetic Model of 89Zr-adalimumab in Healthy and Uveitis Diseased Rats

Thursday 16 October, 2025

Introduction. As the incidence and prevalence of eye diseases is expected to increase, the optimisation of dosing strategies and the…

Read more